Clifford Kashtan, MD

Dr. Kashtan is a tenured Professor of Pediatrics and board-certified pediatric nephrologist with over 30 years of clinical experience. Dr. Kashtan has a particular interest in genetic kidney diseases. He is an internationally recognized authority on Alport syndrome, founder and Executive Director of the Alport Syndrome Treatments and Outcomes Registry (ASTOR), and a member of the Medical Advisory Board of the Alport Syndrome Foundation. Dr. Kashtan has authored numerous original research articles, reviews and book chapters on the biology, diagnosis, and treatment of Alport syndrome. His original research articles on Alport syndrome include basic laboratory studies, animal experiments, and clinical research. Dr. Kashtan developed methods for diagnosing Alport syndrome by examining type IV collagen chains in kidney and skin biopsies. He is the author of the Alport syndrome entries at the online resources UpToDate and GeneReviews. He has lectured on Alport syndrome at numerous institutions and meetings, both nationally and internationally, to professional and lay audiences. Dr. Kashtan regularly consults with biopharmaceutical companies interested in developing novel therapies for Alport syndrome, including advising on clinical trial design, and has served as a site investigator for several clinical trials focused on Alport syndrome.